Leading Financial Service Provider in India | Canara Bank Securities Ltd

Bal Pharma Ltd.

May 29, 04:01 BSE 90.25 ( -6.61 -6.82%)

Volume12072

Prev. Close
96.86

Open Price
91.51

Today's Low / High

89.00 94.60

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

59.69 112.97

May 29, 03:59 NSE 90.12( -6.31 -6.54%)

Volume73218

Prev. Close
96.43

Open Price
95.99

Today's Low / High

88.00 96.97

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.)
90.12 (1062)

52 Wk Low / High

60.00 111.18

Market Cap. ( ₹ in Cr. )	143.48	P/BV	1.79	Book Value ( ₹ )	50.32
52 Week High/Low ( ₹ )	111/60	FV/ML	10/1	P/E(X)	22.70
Book Closure	25/09/2025	EPS ( ₹ )	3.97	Div Yield (%)	1.33

(₹ in Crs.)

Particulars	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25
Net Sales/Income from operations	84.08	87.69	74.02	65.87	81.88
Total Income From Operations	84.08	87.69	74.02	65.87	81.88

EXPENDITURE
Consumption of Raw Materials	41.14	43.51	40.29	36.03	38.70
Purchase of Traded Goods	1.42	2.04	1.78	3.98	6.97
Increase/Decrease in Stocks	-4.23	0.61	-2.14	-6.47	-1.70
Employees Cost	18.07	17.32	16.27	14.80	15.49
Depreciation	3.06	3.23	2.27	2.52	2.18
Other Expenses	17.12	14.66	12.09	11.46	14.77
Total Expenses	76.57	81.37	70.57	62.33	76.42

P/L Before Other Inc. , Int., Excpt. Items & Tax	7.51	6.32	3.46	3.54	5.46
Other Income	-0.24	0.33	1.12	0.72	1.08
P/L Before Interest, Excpt. Items & Tax	7.27	6.64	4.58	4.26	6.54
Interest	4.06	4.85	3.86	4.05	3.95
P/L Before Exceptional Items & Tax	3.22	1.79	0.72	0.21	2.59
P/L Before Tax	3.22	1.79	0.72	0.21	2.59
Tax	-0.39	0.00	0.00	0.00	-2.83
P/L After Tax from Ordinary Activities	3.60	1.79	0.72	0.21	5.42
Net Profit/Loss For the Period	3.60	1.79	0.72	0.21	5.42
Minority Interest	-0.01	-0.01	-0.01	-0.01	0.02
Net P/L After Minority Interest & Share Of Associates	3.59	1.78	0.71	0.20	5.43

Equity Share Capital	15.92	15.92	15.92	15.92	15.92
EPS Before Extra Ordinary *
Basic EPS (Rs.)	2.26	1.12	0.45	0.13	3.40
Diluted EPS (Rs.)	2.26	1.12	0.45	0.13	3.40
EPS After Extra Ordinary *
Basic EPS (Rs.)	2.26	1.12	0.45	0.13	3.40
Diluted EPS (Rs.)	2.26	1.12	0.45	0.13	3.40

PBITOE Margin (%)	8.93	7.20	4.67	5.37	6.66
PBTE Margin (%)	3.82	2.04	0.96	0.31	3.16
PBT Margin (%)	3.82	2.04	0.96	0.31	3.16
PAT Margin (%)	4.28	2.04	0.96	0.31	6.61
PAT After MI And SOA Margin (%)	4.27	2.02	0.95	0.30	6.63

Particulars	Mar 26
Net Sales/Income from operations	84.08
Total Income From Operations	84.08

EXPENDITURE
Consumption of Raw Materials	41.14
Purchase of Traded Goods	1.42
Increase/Decrease in Stocks	-4.23
Employees Cost	18.07
Depreciation	3.06
Other Expenses	17.12
Total Expenses	76.57
P/L Before Other Inc. , Int., Excpt. Items & Tax	7.51
Other Income	-0.24
P/L Before Interest, Excpt. Items & Tax	7.27
Interest	4.06
P/L Before Exceptional Items & Tax	3.22
P/L Before Tax	3.22
Tax	-0.39
P/L After Tax from Ordinary Activities	3.60
Net Profit/Loss For the Period	3.60
Minority Interest	-0.01
Net P/L After Minority Interest & Share Of Associates	3.59
Equity Share Capital	15.92
EPS Before Extra Ordinary *
Basic EPS (Rs.)	2.26
Diluted EPS (Rs.)	2.26
EPS After Extra Ordinary *
Basic EPS (Rs.)	2.26
Diluted EPS (Rs.)	2.26
PBITOE Margin (%)	8.93
PBTE Margin (%)	3.82
PBT Margin (%)	3.82
PAT Margin (%)	4.28
PAT After MI And SOA Margin (%)	4.27

Markets

Quarterly Results

QUARTERLY RESULTS

Bal Pharma Ltd.